Dr Reddys Laboratories (RDY) Non-Current Assets (2012 - 2026)

Dr Reddys Laboratories (RDY) recorded quarterly Non-Current Assets of $3.0 billion in Q1 2026, up 0.83% quarter-over-quarter from $3.0 billion in Q3 2025, and up 8.18% on a YoY basis from $2.8 billion in Q1 2025.

Dr Reddys Laboratories (RDY) Non-Current Assets (2012 - 2026) Analysis & Trends

Dr Reddys Laboratories' Non-Current Assets history runs 14 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 8.18% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $3.0 billion (up 8.18% YoY), while the FY2026 annual figure was $3.0 billion, up 3.94% from the prior year.
  • Non-Current Assets was $3.0 billion for Q1 2026 at Dr Reddys Laboratories, up from $3.0 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $3.0 billion in Q1 2026 to a low of $32.7 million in Q1 2022.
  • Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2023.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets slipped 6.95% in 2022, then jumped 6031.16% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $1.4 billion in 2022, then increased by 8.12% to $1.6 billion in 2023, then soared by 66.24% to $2.6 billion in 2024, then advanced by 15.71% to $3.0 billion in 2025, then gained by 0.83% to $3.0 billion in 2026.
  • The last three Non-Current Assets figures came in at $3.0 billion (Q1 2026), $3.0 billion (Q3 2025), and $2.8 billion (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 26.33 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 8.68 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 3.84 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2.47 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 9.64 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.90 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.22 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.40 Bn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn 3.03 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.03 Bn
Sep 30, 2025 3.01 Bn
Mar 31, 2025 2.80 Bn
Sep 30, 2024 2.60 Bn
Mar 31, 2024 45.75 Mn
Sep 30, 2023 1.56 Bn
Mar 31, 2023 41.02 Mn
Sep 30, 2022 1.45 Bn
Mar 31, 2022 32.72 Mn
Sep 30, 2021 1.56 Bn
Mar 31, 2021 12.23 Mn
Sep 30, 2020 1.59 Bn
Mar 31, 2020 10.10 Mn
Sep 30, 2019 1.61 Bn
Mar 31, 2019 5.30 Mn
Sep 30, 2018 1.69 Bn
Mar 31, 2018 5.39 Mn
Sep 30, 2017 1.89 Bn
Mar 31, 2017 4.42 Mn
Sep 30, 2016 1.13 Bn